HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Christensen, B. Articles by Thelle, D. S Search for Related Content PubMed PubMed Citation Articles by Christensen, B. Articles by Thelle, D. S Agricola Articles by Christensen, B. Articles by Thelle, D. S

Abstention from filtered coffee reduces the concentrations of plasma homocysteine and serum cholesterol—a randomized controlled trial^1,2,3

From the Departments of Medical Genetics, Clinical Chemistry, and Epidemiology and Health Surveillance, Ullevål University Hospital, Oslo, and the Institute of Medical Genetics and the Institute of General Practice and Community Medicine, Department of Epidemiological Research, University of Oslo.

² Supported by grants from the Institute for Scientific Information on Coffee and the Physiological Effects of Coffee.

³ Address reprint requests to B Christensen, Department of Medical Genetics, Ullevål University Hospital, N-0407 Oslo, Norway. E-mail: benedicte. christensen{at}ioks.uio.no.

	ABSTRACT

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES

 
Background: Elevated concentrations of plasma total homocysteine (tHcy) and serum total cholesterol are risk factors for ischemic heart disease (IHD). Previous studies showed that the consumption of very high doses of unfiltered coffee increases tHcy and total cholesterol.

Objective: A prospective intervention study was performed to assess the effects of coffee consumption on the concentrations of tHcy and total cholesterol by using doses and brewing methods common in southeastern Norway.

Design: The study was an unblinded, controlled trial with 191 healthy, nonsmoking, coffee-drinking volunteers aged 24–69 y randomly assigned to 3 groups who were asked to consume for 6 consecutive weeks no coffee, 1–3 cups (175–525 mL)/d, or 4 cups(700 mL)/d prepared in the manner to which they were accustomed. Blood samples were drawn when the subjects were randomly assigned and at 3 and 6 wk of the trial. Dietary data were collected by questionnaire.

Results: Ninety-seven percent of the participants reported being regular consumers of caffeinated filtered coffee. Abstention from coffee for 6 wk was associated with a decrease in the tHcy concentration of 1.08 µmol/L and a decrease in the total cholesterol concentration of 0.28 mmol/L in participants who had been drinking on average 4 cups of filtered coffee daily for the past year. Adjustments for several possible confounders did not alter the results.

Conclusion: Abstention from filtered coffee in doses that are commonly consumed was associated with lower concentrations of tHcy and total cholesterol.

Key Words: Filtered coffee • homocysteine • cholesterol • folate • ischemic heart disease

	INTRODUCTION

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES

 
Coffee has attracted interest for a long time as a potential health hazard. Although early observations indicated a relation between the occurrence of ischemic heart disease (IHD) and coffee intake, later studies in different population groups showed inconsistent results (1–5). In the mortality follow-up of Norwegian men and women, Tverdal et al (4) showed that coffee consumption is strongly related to IHD mortality. Part of this association could be explained by a cholesterol-raising effect of terpenoids [which was found to be particularly pronounced in unfiltered coffee (6, 7)] or by cigarette smoking, but a significantly increased risk remained even after adjustment for serum total cholesterol and smoking. This seemingly unexplained association could either be a direct effect of coffee through unknown risk factors not adjusted for or could reflect an atherothrombogenic lifestyle among heavy coffee drinkers (8). The former explanation gained increased credibility because of the cross-sectional report from The Hordaland Homocysteine Study of a significant positive relation between coffee consumption and total homocysteine (tHcy) (9, 10) in 14000 Norwegian consumers of filtered, unfiltered, and instant, but not decaffeinated, coffee (11). The association was significant even after adjustment for the intake of B vitamins and other nutritional habits that were expected to influence the concentration of tHcy.

A recent intervention study (12) showed that very high intake of unfiltered coffee (1 L/d) increased plasma tHcy by 10% (from 12.8 to 14.0 µmol/L). Although the authors were not able to conclude whether this association depends on the brewing method, it was suggested that unfiltered coffee is more likely to increase tHcy than is filtered coffee. It was speculated that the findings in The Hordaland Homocysteine Study with respect to both tHcy and total cholesterol might be explained by underreporting of consumption of unfiltered coffee.

To assess the coffee-tHcy as well as the coffee–total cholesterol association, we carried out a randomized intervention trial while controlling for both dietary habits and brewing methods. Because cigarette smoking has been associated with low folate concentrations and elevated tHcy concentrations, only nonsmokers were included.

	SUBJECTS AND METHODS

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES

 
Trial design and sample size calculation
The study was organized as a prospective, unblinded controlled trial with the participants randomly assigned to 3 different treatment groups that were to consume for 6 consecutive weeks no coffee, 1–3 cups (175–525 mL) of coffee/d, or 4 cups (700 mL) of coffee/d. On the basis of the differences observed in the cross-sectional study (11), we estimated the expected difference in tHcy between the 2 extreme groups to be on the order of 1.5 µmol/L. Given a statistical power of 0.9 (90% probability for detecting this difference if it is there) at a significance level of 0.05, each group would need 60 persons.

Subjects and procedure
The participants were recruited by an advertisement we placed in the largest newspaper in Oslo. Inclusion criteria were age 24–69 y, a history of daily consumption of coffee for 5 y, and no daily tobacco smoking for the past 6 mo. All participants gave written consent to participation after they were provided with oral and written information; on entering the trial, they completed a questionnaire relating to exclusion criteria. Approval for the study was obtained from the Regional Research Ethics Committee. Exclusion criteria included clinically recognized chronic diseases, such as cardiovascular diseases, cancer, renal disorders, liver disease, diabetes mellitus; the use of antiepileptic or cholesterol-lowering drugs; recognized vitamin deficiency in the past; and serum folate concentrations below the lower value of the reference range (6–24 nmol/L). All participants were asked to follow their usual diet during the trial: the coffee-consuming groups were permitted to drink the type of coffee to which they were accustomed. Body weight and blood pressure were monitored throughout the 6-wk period in the 3 intervention groups. Each participant was seen at 3 visits that were spaced 3 wk apart. Dietary habits were recorded at the start and end of the trial.

Nonfasting blood samples were drawn at the time of random assignment and 3 and 6 wk after the start of the trial. Plasma was prepared from EDTA-treated blood within 2 h after storage at 4°C, and blood serum was prepared without additives after storage at room temperature. Before analysis, plasma and serum were stored at -20°C, and blood for the whole blood folate analysis was stored at -70°C. The tHcy, folate, and lipid concentrations were determined within 3 mo, and vitamin B-12 concentrations were determined 7 mo after the trial was finished. All 3 samples from each patient were always analyzed consecutively in the same run.

Effect variables
Plasma tHcy was measured by using the Abbott IMX homocysteine assay (Abbott Laboratories, Abbott Park, IL; CV: 4%) and the lipids in serum [HDL cholesterol, triacylglycerol, LDL cholesterol, and lipoprotein(a)] were measured by the routine methods used in our hospital. Total cholesterol was measured by an enzymatic assay analyzed on a Cobas Integra instrument (Roche, Basel, Switzerland; CV: 3%). Serum folate in whole blood and vitamin B-12 were measured with an AutoDelphia instrument (Wallac Oy, Turku, Finland; CV: 4.5%). The analytic principle for the folate assays was based on the measurement of time-resolved fluorescence from a solid-phase immunoassay with a competitive reaction between europium-labeled pteroylglutamic acid and sample folate for a limited amount of folate-binding protein. The analytic principle for the vitamin B-12 fluoroimmunoassay was based on a competitive reaction between europium-labeled vitamin B-12 and sample vitamin B-12 for a limited amount of binding sites on intrinsic factor. The effects on the biochemical variables were assessed as the differences between the first and the last measurement within each group, as well as the differences between the changes within the groups. The dietary habits were assessed at the beginning and end of the trial with a validated Norwegian food-frequency questionnaire (13, 14). After the intervention period, the participants were asked about their self-perceived changes in the intake of important foods and drinks. Height, weight, and blood pressure were recorded at the beginning of the trial and after 6 wk.

Statistical methods
Statistical analyses were carried out by using the computer program SPSS version 9.0 for WINDOWS (SPSS Inc, Chicago). The paired t test was used for the comparison of the differences of the biochemical variables taken between the start of the trial and after 6 wk. To adjust for possible confounding effects on the differences of tHcy and total cholesterol, analysis of covariance as well as multiple linear regression analyses with sex, age, change in body mass index (BMI), alteration in folate concentrations, and self-reported intake of tea and fruit juice were carried out. Statistical significance was P < 0.05.

	RESULTS

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES

 
Two hundred fourteen ostensibly healthy persons were recruited; 23 were excluded because of low serum folate concentrations (<6 nmol/L), which left a total of 191 participants. Two of these did not come to their scheduled visits, and 4 decided to withdraw from the trial. Ninety-seven percent of the participants had been consuming filtered brewed, caffeinated coffee habitually before the study, and the average amount consumed was 4.9 cups/d. The questionnaire to assess adherence to the group assignment and possible changes in diet during the trial was completed by 182 (95%) of the participants.

The baseline characteristics of the eligible participants according to treatment group are shown in Table 1. There was a slightly higher proportion of female participants among the coffee abstainers, but there were no other significant differences between groups.

View larger version (18K): [in this window] [in a new window]   FIGURE 1. . The mean (±SD) concentrations of serum total cholesterol in the 3 treatment groups 0, 3, and 6 wk after the start of the trial.

View larger version (15K): [in this window] [in a new window]   FIGURE 2. . The mean (±SD) concentrations of plasma total homocysteine (tHcy) in the 3 treatment groups 0, 3, and 6 wk after the start of the trial.

View larger version (16K): [in this window] [in a new window]   FIGURE 3. . The mean (±SD) concentrations of serum folate in the 3 treatment groups 0, 3, and 6 wk after the start of the trial.

	DISCUSSION

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES

Our results are also in line with the recently published findings of increased plasma tHcy after daily consumption of 1 L unfiltered coffee (12). The fact that the magnitude of the effect on tHcy was similar in our study with filtered coffee indicates that this effect is caused by compounds that are not removed in the filtering process.

The effect of coffee on tHcy could be mediated directly or indirectly by the metabolism of the B vitamins folate, vitamin B-6, or vitamin B-12. Of these, the concentration of serum folate is known to be the strongest determinant of the concentration of plasma tHcy, whereas the effects of vitamins B-6 and B-12 are considered to be less important (15). Indeed, the concentration of vitamin B-12 was not influenced by coffee consumption in the present study.

The effect of coffee on whole blood folate was not consistent. The reason may be the short trial period, which lasted an average of only 42 d. The concentration of folate in red blood cells or in whole blood is a measure of intracellular folate status and reflects the folate status during the past 120 d (16).

There was an increased serum folate concentration in the coffee abstainers, but the differences in the folate changes between the groups were not statistically significant. These results cannot support or reject the hypothesis that coffee drinkers have different intakes of folate or that coffee interferes with the uptake of folate from nutrients. The lack of a relation between the effect of coffee on tHcy and an alteration in the concentration of folate is in line with the recent findings of Grubben et al (12).

Dietary trials with subjects consuming a free diet frequently create interpretation problems caused by the need for a constant intake of energy and fluid. Any induced change in the sources of these 2 variables is likely to be compensated for by changes in other sources. This will be of no importance as long as the replacements are inert with regard to the outcome factors. In the present experiment, monitoring of body weight did not indicate any systematic changes in energy intake, but the participants who changed their coffee-drinking habits reported that they compensated for the changes in fluid intake by increasing or decreasing the intake of other beverages. The most common replacements of coffee in this study were black tea and fruit juice. Both drinks have been reported to affect the intake of folate (17), but adjustment for these dietary changes did not change the main results in the trial. This is also in line with the results from The Hordaland Homocysteine Study, in which crude analyses showed that the consumption of black tea was negatively related to tHcy concentrations in coffee drinkers, whereas no significant relation was seen in coffee abstainers. This correlation disappeared after adjustment for smoking habits and vitamin consumption. The coffee-tHcy relation in the present trial, however, remained remarkably stable even after adjustment for all the variables addressed in the study, suggesting a robust association. The possibility that other confounding factors might have influenced the results cannot be ruled out; however, such an influence would have to have been strong if this were the case.

Surprisingly, the effect of coffee on total cholesterol was more pronounced than in the results of previous studies (18). The observation of a decrease in total cholesterol by 0.28 mmol/L in the present study indicates that the terpenoids that cause an elevated concentration of total cholesterol are only partly removed by a coffee filter.

The present study only addresses the issue of a causal relation between coffee intake and the concentrations of some biochemical variables, but the results can be used to assess the possible effects of coffee on IHD risk. The average alteration in tHcy per cup of coffee consumed before the trial was estimated to be 0.22 µmol/L. An increase of 5 µmol tHcy/L is associated with an odds ratio for myocardial infarction of 1.57 (19). This odds ratio would correspond to an increase in coffee consumption of 23 cups of coffee/d. Abstaining from a previous daily consumption of 4 cups of filtered coffee might therefore reduce the homocysteine-attributed risk of IHD by 10%. The Dutch study (12) showed a similar IHD risk with consumption of 6 cups of unfiltered coffee. Abstaining from 4 cups/d would also reduce the concentration of total cholesterol by 0.28 mmol/L and reduce the total cholesterol–attributed risk of IHD by 15% (20).

We conclude that abstaining from even commonly consumed amounts of filtered coffee may lower the concentrations of both tHcy and total cholesterol. It is not obvious that the effect on tHcy is related to alterations in folate status. If there is interference with folate, it may theoretically happen by 3 different mechanisms. First, coffee drinkers could have lower intake of folate-containing food. Second, the intake of coffee could interfere with the absorption of folate from the diet. Third, there might be substances in coffee that interfere with folate-homocysteine metabolism.

	ACKNOWLEDGMENTS

 
We thank Lene Haugen for performing the biochemical analyses and Isabel Nogueira and Maj Elin Storeide for their valuable help with the practical organization of the trial.

	REFERENCES

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES

 

1. Dawber TR, Kannel WB, Gordon T. Coffee and cardiovascular disease: observations from the Framingham study. N Engl J Med 1974; 291:871–4.
2. Heyden S, Tyroler HA, Heiss G, Hames CG, Bartel A. Coffee consumption and mortality: total mortality, stroke mortality, and ischemic heart disease mortality. Arch Intern Med 1978;138:1472–5.[Abstract]
3. Klatsky AL, Friedman GD, Siegelaub AB. Coffee drinking prior to acute myocardial infarction: results from the Kaiser-Permanente epidemiologic study of myocardial infarction. JAMA 1973;226:540–3.[Medline]
4. Tverdal A, Stensvold I, Solvoll K, Foss OP, Lund-Larsen P, Bjartveit K. Coffee consumption and death from coronary heart disease in middle aged Norwegian men and women. BMJ 1990;300:566–9.
5. Yano K, Rhoads GG, Kagan A. Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawaii. N Engl J Med 1977;297:405–9.[Abstract]
6. Thelle DS. Coffee, tea, and coronary heart disease. Curr Opin Lipidol 1995;6:25–7.[Medline]
7. Weusten van der Wouw MPME. Identity of the cholesterol-raising factor from boiled coffee and its effects on liver function enzymes. J Lipid Res 1994;35:721–33.[Abstract]
8. Jacobsen BK, Thelle DS. The Tromsø Heart Study: is coffee drinking an indicator of a life style with high risk for ischemic heart disease? Acta Med Scand 1987;222:215–21.[Medline]
9. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049–57.[Abstract]
10. Nygard O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995;274:1526–33.[Abstract]
11. Nygard O, Refsum H, Ueland PM, et al. Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. Am J Clin Nutr 1997;65:136–43.[Abstract/Free Full Text]
12. Grubben MJ, Boers GH, Blom HJ, et al. Unfiltered coffee increases plasma homocysteine concentrations in healthy volunteers: a randomized trial. Am J Clin Nutr 2000;71:480–4.[Abstract/Free Full Text]
13. Andersen L, Solvoll K, Johansson L, Salminen I, Aro A, Drevon C. Evaluation of a food frequency questionnaire with weighed records, fatty acids and alpha-tocopherol in adipose tissue and serum. Am J Epidemiol 1999;150:75–87.[Abstract/Free Full Text]
14. Nes M, Andersen F, Solvoll K, et al. Accuracy of a quantitative food frequency questionnaire applied in elderly Norwegian women. Eur J Clin Nutr 1992;46:809–21.[Medline]
15. Verhoef P, Stampfer MJ, Buring JE, et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B₆, B₁₂, and folate. Am J Epidemiol 1996;143:845–59.[Abstract/Free Full Text]
16. Chanarin I. The megaloblastic anaemias. 3rd ed. London: Blackwell Scientific Publications, 1990.
17. Chen TS, Lui C, Smith C. Folacin content of tea. J Am Diet Assoc 1983;82:627–32.[Medline]
18. Bak A, Grobbee DE. The effect on serum cholesterol levels of coffee brewed by filtering or boiling. N Engl J Med 1989;321:1432–7.[Abstract]
19. Christensen B, Landaas S, Stensvold I, et al. Whole blood folate, homocysteine in serum, and risk of first myocardial infarction. Atherosclerosis 1999;147:317–26.[Medline]
20. Stensvold I, Tverdal A, Urdal P, Graff-Iversen S. Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women. BMJ 1993;307: 1318–22.

This article has been cited by other articles:

				A. Ulvik, S. E. Vollset, G. Hoff, and P. M. Ueland Coffee Consumption and Circulating B-Vitamins in Healthy Middle-Aged Men and Women Clin. Chem., September 1, 2008; 54(9): 1489 - 1496. [Abstract] [Full Text] [PDF]

				J. A Greenberg, C. N Boozer, and A. Geliebter Coffee, diabetes, and weight control. Am. J. Clinical Nutrition, October 1, 2006; 84(4): 682 - 693. [Abstract] [Full Text] [PDF]

				E. Nurk, G. S Tell, S. E Vollset, O. Nygard, H. Refsum, R. M Nilsen, and P. M Ueland Changes in lifestyle and plasma total homocysteine: the Hordaland Homocysteine Study Am. J. Clinical Nutrition, May 1, 2004; 79(5): 812 - 819. [Abstract] [Full Text] [PDF]

				C. Chrysohoou, D. B Panagiotakos, C. Pitsavos, A. Zeimbekis, A. Zampelas, L. Papademetriou, C. Masoura, and C. Stefanadis The associations between smoking, physical activity, dietary habits and plasma homocysteine levels in cardiovascular disease-free people: the 'ATTICA' study Vascular Medicine, May 1, 2004; 9(2): 117 - 123. [Abstract] [PDF]

				J. E. James Critical Review of Dietary Caffeine and Blood Pressure: A Relationship That Should Be Taken More Seriously Psychosom Med, January 1, 2004; 66(1): 63 - 71. [Abstract] [Full Text] [PDF]

				A. De Bree, W. M. M. Verschuren, D. Kromhout, L. A. J. Kluijtmans, and H. J. Blom Homocysteine Determinants and the Evidence to What Extent Homocysteine Determines the Risk of Coronary Heart Disease Pharmacol. Rev., December 1, 2002; 54(4): 599 - 618. [Abstract] [Full Text] [PDF]

				B. Christensen, A. Mosdol, and D. S Thelle Reply to TMS Wolever Am. J. Clinical Nutrition, May 1, 2002; 75(5): 949 - 950. [Full Text]

				T. M. Wolever Abstention from filtered coffee reduces the concentrations of plasma homocysteine and serum cholesterol Am. J. Clinical Nutrition, May 1, 2002; 75 (5): 948 - 949. [Full Text] [PDF]

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Christensen, B. Articles by Thelle, D. S Search for Related Content PubMed PubMed Citation Articles by Christensen, B. Articles by Thelle, D. S Agricola Articles by Christensen, B. Articles by Thelle, D. S